We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$34.3M
3
MRNA icon
Moderna
MRNA
+$29.3M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.3M
5
MTCH icon
Match Group
MTCH
+$9.52M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$35.7M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
AAPL icon
Apple
AAPL
+$13.2M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.57M

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVLG icon
2351
Covenant Logistics
CVLG
$865M
$122K ﹤0.01%
+8,820
New +$98.7K
FHTX icon
2352
Foghorn Therapeutics
FHTX
$394M
$121K ﹤0.01%
+8,683
New +$96.1K
TNYA icon
2353
Tenaya Therapeutics
TNYA
$171M
$121K ﹤0.01%
+5,857
New +$126K
EBTC
2354
DELISTED
Enterprise Bancorp
EBTC
$121K ﹤0.01%
+3,354
New +$112K
INST
2355
DELISTED
Instructure Holdings, Inc.
INST
$121K ﹤0.01%
+5,336
New +$114K
BOLT icon
2356
Bolt Biotherapeutics
BOLT
$6.63M
$120K ﹤0.01%
+476
New +$135K
ACTG icon
2357
Acacia Research
ACTG
$455M
$120K ﹤0.01%
+17,691
New +$108K
MLNK
2358
DELISTED
MeridianLink
MLNK
$120K ﹤0.01%
+5,371
New +$133K
UTMD icon
2359
Utah Medical Products
UTMD
$230M
$120K ﹤0.01%
+1,293
New +$114K
FUV
2360
DELISTED
Arcimoto, Inc. Common Stock
FUV
$120K ﹤0.01%
523
– –
FLIC
2361
DELISTED
First of Long Island Corp
FLIC
$119K ﹤0.01%
5,760
-4,164
-42% -$87.5K
AVNW icon
2362
Aviat Networks
AVNW
$282M
$119K ﹤0.01%
3,608
– –
APLT
2363
DELISTED
Applied Therapeutics
APLT
$118K ﹤0.01%
7,129
– –
COGT icon
2364
Cogent Biosciences
COGT
$6.76B
$118K ﹤0.01%
+14,022
New +$107K
LOTZ
2365
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$118K ﹤0.01%
+30,940
New +$133K
TPC
2366
Tutor Perini Cor
TPC
$5.05B
$118K ﹤0.01%
9,064
-6,400
-41% -$87.4K
EVCM icon
2367
EverCommerce
EVCM
$1.76B
$117K ﹤0.01%
+7,125
New +$131K
EVER icon
2368
EverQuote
EVER
$867M
$117K ﹤0.01%
6,305
– –
CMBM
2369
DELISTED
Cambium Networks
CMBM
$117K ﹤0.01%
3,242
– –
MSON
2370
DELISTED
Misonix Inc
MSON
$117K ﹤0.01%
+4,619
New +$114K
NEXI
2371
DELISTED
NexImmune, Inc. Common Stock
NEXI
$117K ﹤0.01%
+308
New +$103K
RXDX
2372
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$116K ﹤0.01%
+4,911
New +$116K
SB icon
2373
Safe Bulkers
SB
$760M
$116K ﹤0.01%
+22,514
New +$86.9K
JXN icon
2374
Jackson Financial
JXN
$8.85B
$116K ﹤0.01%
+4,462
New +$121K
NPK icon
2375
National Presto Industries
NPK
$998M
$116K ﹤0.01%
1,408
– –
93 94
95
96 97

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.